The Kingsley Clinic

Basal Cell Carcinoma: Symptoms, Diagnosis, and Treatment Options

Introduction

Basal cell carcinoma (BCC) is the most common type of skin cancer, affecting millions of people worldwide each year. It originates in the basal cells, which are located in the outermost layer of the skin, known as the epidermis. While BCC tends to grow slowly and rarely spreads to other parts of the body, it can cause significant damage to the skin and surrounding tissues if left untreated. This article aims to provide a comprehensive overview of basal cell carcinoma, including its risk factors, symptoms, diagnosis, and treatment options. By understanding this condition, patients can take proactive steps to protect their skin and seek timely medical care when needed.

This article will cover the risk factors for basal cell carcinoma, common symptoms, diagnostic tests, treatments, and self-care measures that patients can adopt to manage their condition.

Description of Basal Cell Carcinoma

Basal cell carcinoma (BCC) is a form of skin cancer that begins in the basal cells, which are responsible for producing new skin cells as old ones die off. BCC most commonly develops in areas frequently exposed to the sun, such as the face, neck, and arms. Although BCC generally grows slowly and rarely metastasizes, it can become invasive if left untreated, leading to disfigurement or damage to surrounding tissues.

BCC typically starts as a small, pearly bump or a flat, flesh-colored lesion. Over time, these lesions may grow, become more prominent, and may even bleed or crust over. Despite its slow growth, BCC can become locally aggressive, penetrating deeper layers of the skin and affecting underlying tissues like muscles and bones.

According to the American Cancer Society, BCC accounts for about 80% of all skin cancers in the United States, with an estimated 3.6 million cases diagnosed annually. While BCC is rarely life-threatening, early detection and treatment are crucial to prevent complications and reduce the risk of recurrence.

Risk Factors for Developing Basal Cell Carcinoma

Lifestyle Risk Factors

One of the most significant lifestyle risk factors for developing basal cell carcinoma is excessive exposure to ultraviolet (UV) radiation from the sun or tanning beds. Individuals who spend a lot of time outdoors without adequate sun protection, such as sunscreen or protective clothing, are at a higher risk of developing BCC. Additionally, frequent sunburns, especially during childhood or adolescence, increase the likelihood of developing skin cancer later in life.

Indoor tanning bed use is another major risk factor, as these devices emit concentrated UV radiation. Studies show that regular tanning bed users are at a much higher risk of developing BCC and other skin cancers.

Living in regions with high sun exposure, such as tropical or subtropical areas, also increases the risk. Similarly, outdoor workers, like farmers, construction workers, and lifeguards, are more likely to develop BCC due to prolonged sun exposure.

Medical Risk Factors

In addition to lifestyle factors, certain medical conditions and treatments can increase the risk of basal cell carcinoma. Individuals with weakened immune systems, such as those undergoing organ transplants or receiving immunosuppressive medications, are at higher risk because the immune system plays a crucial role in detecting and destroying abnormal cells, including cancerous ones.

Chronic skin conditions, such as eczema or psoriasis, can also elevate the risk, especially if the skin is frequently inflamed or damaged. Additionally, individuals with a history of skin cancer are more likely to develop BCC again, as their skin may be more susceptible to cancerous changes.

Genetic and Age-Related Risk Factors

Certain genetic factors can predispose individuals to basal cell carcinoma. For instance, people with a family history of skin cancer are more likely to develop BCC. Additionally, individuals with genetic syndromes like basal cell nevus syndrome (Gorlin syndrome) are at a significantly higher risk of developing multiple BCCs throughout their lifetime.

Age is another important risk factor. While BCC can occur at any age, it is most commonly diagnosed in individuals over 50, likely due to cumulative sun exposure. However, younger individuals with fair skin and a history of sunburns can also develop BCC.

People with fair skin, light-colored eyes, and blonde or red hair are more susceptible to BCC because they have less melanin, the pigment that helps protect the skin from UV radiation.

Clinical Manifestations of Basal Cell Carcinoma

Painless Sore

Approximately 70% of basal cell carcinoma (BCC) patients experience a painless sore. This sore often appears early in the disease and may be mistaken for a minor skin irritation or injury. A key distinguishing feature is that the sore does not heal over time. It typically appears on sun-exposed areas like the face, neck, or arms and can persist for weeks or months. While the sore itself may not be painful, it can become tender if irritated or infected.

Shiny Bump

About 60% of BCC patients develop a shiny bump, which is often pearly or translucent and may appear pink, red, or white. In individuals with darker skin tones, the bump may appear brown or black, resembling a mole. Shiny bumps are more common in early-stage BCC and typically appear on sun-exposed areas. These bumps result from abnormal cell growth in the basal layer of the skin, leading to a raised, smooth surface.

Flat, Scaly Patch

Flat, scaly patches occur in roughly 30% of BCC cases, particularly in patients with superficial basal cell carcinoma. These patches are often red or pink and may feel rough or dry. Commonly found on the trunk, shoulders, or back, these patches can be mistaken for eczema or psoriasis, delaying diagnosis. If a flat, scaly patch persists despite treatment for other skin conditions, it should be evaluated for BCC.

Red or Irritated Area

Approximately 40% of BCC patients report a red or irritated area on their skin. This area may resemble a rash or sunburn that does not improve over time. The irritation occurs because cancerous cells cause inflammation in the surrounding skin tissue. These areas are often found on the face, ears, or neck and may be itchy or uncomfortable, though not typically painful. Persistent redness or irritation in a sun-exposed area should prompt further evaluation.

Open Sore

Open sores are seen in about 50% of BCC cases and are often a sign of more advanced disease. These sores may bleed, ooze, or crust over and can be slow to heal. Open sores develop when cancerous cells invade deeper skin layers, causing tissue breakdown. If an open sore does not heal within a few weeks, medical attention is necessary.

Waxy Scar

Waxy scars, also known as morpheaform BCC, occur in about 10% of cases and are more common in advanced stages. These scars appear as flat, white, or yellowish areas on the skin and may resemble a scar from a previous injury. The skin in the affected area may feel tight or firm. This type of BCC is often more aggressive and can invade deeper skin layers, making early detection and treatment crucial.

Bleeding or Oozing Lesion

Bleeding or oozing lesions are present in approximately 50% of BCC cases, particularly in more advanced stages. These lesions may bleed spontaneously or after minor trauma, such as rubbing or scratching. Oozing occurs when fluid or blood leaks from the lesion, leading to crusting or scabbing. Persistent bleeding or oozing should be evaluated by a healthcare provider.

Crusted Area

Crusted areas are seen in about 40% of BCC patients and are often associated with open sores or bleeding lesions. The crust forms from dried blood, serum, or other fluids that leak from the lesion. These areas may appear rough or scab-like and can be mistaken for benign skin conditions. A crusted area that does not heal should raise suspicion for BCC and prompt further evaluation.

Raised Growth

Raised growths occur in approximately 35% of BCC cases and are typically seen in nodular basal cell carcinoma. These growths are often pink, red, or flesh-colored and may have a rolled border. Raised growths are most commonly found on the face, neck, or arms and can be mistaken for benign skin conditions. If a raised growth changes in size, shape, or color, it should be evaluated for BCC.

Diagnostic Evaluation of Basal Cell Carcinoma

Diagnosing basal cell carcinoma (BCC) typically involves a clinical examination, patient history, and diagnostic tests. A healthcare provider will assess the lesion’s appearance, ask about its duration, and note any changes over time. If BCC is suspected, a biopsy is usually performed to confirm the diagnosis. In some cases, imaging tests may be used to determine the extent of the cancer, especially if it is suspected to have spread to deeper tissues or nearby structures.

Skin Biopsy

A skin biopsy is the most definitive test for diagnosing BCC. During a biopsy, a healthcare provider removes a small sample of the suspicious lesion for further examination. The sample is sent to a pathology lab, where it is analyzed under a microscope to look for cancerous cells. The biopsy helps determine the type of skin cancer, its depth, and whether it has invaded surrounding tissues.

Dermatoscopy

Dermatoscopy is a non-invasive diagnostic tool used to examine skin lesions in greater detail. This test involves using a dermatoscope, a handheld device with a magnifying lens and light source, to visualize the skin’s surface and underlying structures. Dermatoscopy is particularly useful for distinguishing between different types of skin lesions, including BCC, melanoma, and benign growths.

Imaging Tests

Imaging tests, such as ultrasound, MRI, or CT scans, are not routinely used to diagnose BCC but may be employed in cases where the cancer is suspected to have spread to deeper tissues or nearby structures. These tests provide detailed images of the skin and underlying tissues, allowing healthcare providers to assess the extent of the cancer. Imaging is particularly useful for large or aggressive BCCs that may have invaded muscles, bones, or other organs.

Mohs Micrographic Surgery

Mohs micrographic surgery is both a diagnostic and therapeutic procedure used to treat BCC, particularly in high-risk areas like the face. During the procedure, the surgeon removes the visible tumor and examines the tissue under a microscope in real-time. If cancerous cells are found at the margins, additional layers are removed until no cancerous cells remain. This technique allows for precise removal of cancerous tissue while sparing as much healthy tissue as possible.

Punch Biopsy

A punch biopsy is a type of skin biopsy used to diagnose BCC by removing a small, circular sample of tissue from the suspicious lesion. The procedure is performed using a punch tool, which cuts through the skin to obtain a full-thickness sample. The tissue sample is sent to a pathology lab for microscopic examination to determine whether cancerous cells are present.

What if All Tests are Negative but Symptoms Persist?

If all diagnostic tests come back negative for BCC but symptoms persist, it’s important to follow up with your healthcare provider. Persistent symptoms, such as a non-healing sore or a new skin lesion, may indicate another underlying condition that requires further investigation. Your healthcare provider may recommend additional testing, such as repeat biopsies, imaging, or referral to a dermatologist for a second opinion. Monitoring your skin and reporting any changes or new symptoms is crucial for early detection and effective treatment.

Health Conditions with Similar Symptoms to Basal Cell Carcinoma

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC) is another form of skin cancer that originates in the squamous cells, which make up the outermost layer of the skin. It often presents as a scaly, red patch, an open sore, or a wart-like growth. If left untreated, SCC can penetrate deeper into the skin and potentially spread to other parts of the body.

How to Differentiate Between Squamous Cell Carcinoma and Basal Cell Carcinoma

Both SCC and basal cell carcinoma can manifest as scaly patches, sores, or growths, making them difficult to distinguish. However, SCC typically appears as rough, scaly patches that may bleed or crust, while basal cell carcinoma is more likely to present as a pearly or waxy bump. SCC is also more common in sun-exposed areas such as the face, ears, neck, and hands, similar to basal cell carcinoma.

A biopsy is often required to differentiate between the two. SCC will reveal abnormal squamous cells, while basal cell carcinoma will show abnormal basal cells. SCC has a higher likelihood of spreading (metastasizing), whereas basal cell carcinoma rarely spreads beyond the original tumor site. If you notice a rough, scaly patch that doesn’t heal, especially in a sun-exposed area, it’s important to seek medical evaluation.

Melanoma

Melanoma is the most dangerous type of skin cancer, developing in melanocytes, the cells responsible for producing skin pigment. It often appears as a new mole or a change in an existing mole. Melanoma can spread rapidly, making early detection critical.

How to Differentiate Between Melanoma and Basal Cell Carcinoma

While both melanoma and basal cell carcinoma can appear as abnormal growths, there are key differences. Melanoma often presents as a dark, irregularly shaped mole or spot, whereas basal cell carcinoma typically appears as a pearly bump or flat, flesh-colored lesion. The “ABCDE” rule is helpful for identifying melanoma: Asymmetry, Border irregularity, Color variation, Diameter larger than a pencil eraser, and Evolving (changing over time). Basal cell carcinoma generally grows more slowly and does not follow the ABCDE pattern.

A biopsy is the definitive way to distinguish between melanoma and basal cell carcinoma. Melanoma is more aggressive and can spread to lymph nodes and other organs, while basal cell carcinoma rarely spreads. If you notice a mole changing in size, shape, or color, or if it starts to bleed, consult a healthcare professional immediately.

Actinic Keratosis

Actinic keratosis (AK) is a precancerous skin condition caused by prolonged sun exposure. It appears as rough, scaly patches or spots on sun-exposed areas like the face, ears, scalp, and hands. While not cancerous, AK can progress to SCC if left untreated.

How to Differentiate Between Actinic Keratosis and Basal Cell Carcinoma

Both AK and basal cell carcinoma can present as rough, scaly patches, particularly in sun-exposed areas. However, AK is typically smaller and feels like sandpaper, while basal cell carcinoma may appear as a pearly bump or flat, flesh-colored lesion. AK is more likely to be red or pink, while basal cell carcinoma may have a translucent or shiny appearance.

A biopsy can distinguish between the two. AK will show precancerous cells, while basal cell carcinoma will show abnormal basal cells. If you notice a rough, scaly patch that doesn’t heal, especially in a sun-exposed area, seek medical evaluation, as AK can progress to SCC over time.

Keratoacanthoma

Keratoacanthoma is a low-grade, rapidly growing skin tumor that resembles SCC. It often appears as a dome-shaped bump with a central crater filled with keratin. While keratoacanthomas grow quickly, they may shrink on their own.

How to Differentiate Between Keratoacanthoma and Basal Cell Carcinoma

Keratoacanthoma and basal cell carcinoma can both appear as raised bumps, but keratoacanthoma grows much faster. It often has a central crater filled with keratin, while basal cell carcinoma may appear as a pearly or waxy bump. Both tend to develop on sun-exposed areas.

A biopsy is necessary to differentiate between the two. Keratoacanthoma will show a well-differentiated squamous cell structure, while basal cell carcinoma will show abnormal basal cells. Although keratoacanthomas may shrink on their own, they are often treated similarly to SCC to prevent complications.

Seborrheic Keratosis

Seborrheic keratosis is a common, non-cancerous skin growth that often appears as a brown, black, or light tan spot. These growths are typically waxy, raised, and have a “stuck-on” appearance. Seborrheic keratosis is harmless and doesn’t require treatment unless it becomes irritated or for cosmetic reasons.

How to Differentiate Between Seborrheic Keratosis and Basal Cell Carcinoma

Seborrheic keratosis and basal cell carcinoma can both present as raised, waxy growths. However, seborrheic keratosis typically has a “stuck-on” appearance and may be brown, black, or tan, while basal cell carcinoma is more likely to appear as a pearly or flesh-colored bump. Seborrheic keratosis is usually painless, while basal cell carcinoma may cause itching or bleeding.

A biopsy can help differentiate between the two. Seborrheic keratosis will show benign cells, while basal cell carcinoma will show abnormal basal cells. Seborrheic keratosis doesn’t require treatment unless it becomes irritated, while basal cell carcinoma requires treatment to prevent further growth.

Dermatofibroma

Dermatofibroma is a common, benign skin growth that often appears as a small, firm bump. It is usually brown or tan and may feel like a hard lump under the skin. Dermatofibromas are harmless and don’t require treatment unless they become painful or irritated.

How to Differentiate Between Dermatofibroma and Basal Cell Carcinoma

Both dermatofibroma and basal cell carcinoma can present as small, raised bumps. However, dermatofibromas are typically firm to the touch and may have a darker color, while basal cell carcinoma is more likely to appear as a pearly or waxy bump. Dermatofibromas are usually painless, while basal cell carcinoma may cause itching or bleeding.

A biopsy can help distinguish between the two. Dermatofibromas will show benign fibrous tissue, while basal cell carcinoma will show abnormal basal cells. Dermatofibromas don’t require treatment unless painful or irritated, while basal cell carcinoma requires treatment to prevent further growth.

Basal Cell Nevus Syndrome

Basal cell nevus syndrome, also known as Gorlin syndrome, is a genetic condition that increases the risk of developing basal cell carcinoma and other tumors. People with this syndrome may develop multiple basal cell carcinomas at a young age, along with other abnormalities like jaw cysts and skeletal defects.

How to Differentiate Between Basal Cell Nevus Syndrome and Basal Cell Carcinoma

Basal cell nevus syndrome and basal cell carcinoma can both present with basal cell carcinomas. However, basal cell nevus syndrome is a genetic condition that often leads to multiple basal cell carcinomas at a young age, while sporadic basal cell carcinoma usually develops later in life due to sun exposure.

Genetic testing can help diagnose basal cell nevus syndrome. In addition to multiple basal cell carcinomas, people with this syndrome may have jaw cysts, skeletal abnormalities, and other tumors. If you have multiple basal cell carcinomas or a family history of the condition, genetic testing may be recommended.

Treatment Options for Basal Cell Carcinoma

Medications

Imiquimod

Imiquimod is a topical cream that stimulates the immune system to attack cancerous cells. It is used to treat superficial basal cell carcinoma by encouraging the body to produce cytokines, which help destroy abnormal skin cells.

This medication is typically applied directly to the affected area five times a week for several weeks. It is most effective for small, superficial basal cell carcinomas and is often used when surgery is not an option or for patients who prefer a non-invasive treatment.

Patients can expect to see redness, swelling, and crusting in the treated area, indicating the immune response is working. The skin usually heals within a few weeks after treatment is completed.

5-Fluorouracil (5-FU)

5-Fluorouracil is a topical chemotherapy cream that works by interfering with the DNA of cancer cells, preventing them from growing and multiplying. It is used to treat superficial basal cell carcinoma.

5-FU is applied directly to the lesion once or twice daily for several weeks. It is especially useful for patients with multiple small lesions or those who cannot undergo surgery. It is commonly used for superficial lesions on the face or other sensitive areas.

Patients may experience redness, irritation, and peeling at the application site. The treatment is generally effective within 6 to 12 weeks, with visible improvement as the abnormal cells are destroyed.

Vismodegib

Vismodegib is an oral medication that targets the hedgehog signaling pathway, which is often overactive in basal cell carcinoma. It is used to treat advanced or metastatic basal cell carcinoma that cannot be treated with surgery or radiation.

This medication is taken daily and is typically reserved for patients with more aggressive or recurrent forms of the disease. It is also used for patients who are not candidates for surgery or radiation therapy.

Vismodegib can help shrink tumors and slow disease progression. Patients may see results within a few weeks, but treatment duration varies based on the severity of the cancer.

Sonidegib

Sonidegib is another oral medication that inhibits the hedgehog signaling pathway, similar to Vismodegib. It is used to treat locally advanced basal cell carcinoma that cannot be treated with surgery or radiation.

Sonidegib is taken daily and is typically prescribed for patients with advanced basal cell carcinoma. It is often used when other treatments, like surgery or radiation, are not viable options.

Patients may experience a reduction in tumor size and a slowing of cancer progression. The treatment response can be seen within weeks to months, depending on the individual case.

Topical Chemotherapy

Topical chemotherapy involves applying cancer-fighting drugs directly to the skin. The most common drug used is 5-fluorouracil, which targets and destroys cancerous cells.

This treatment is typically used for superficial basal cell carcinoma or for patients who cannot undergo surgery. It is applied to the affected area for several weeks, depending on the size and location of the lesion.

Patients can expect irritation, redness, and peeling at the site of application. The treatment is generally effective within 6 to 12 weeks, with visible improvement as the cancerous cells are eliminated.

Radiation Therapy

Radiation therapy uses high-energy beams to kill cancer cells. It is often used for basal cell carcinoma when surgery is not possible or when the cancer is in a difficult-to-treat location, such as the face.

This treatment is typically administered over several sessions, with each session lasting a few minutes. It is often used for older patients or those with large or recurrent tumors.

Radiation therapy can effectively shrink tumors and prevent cancer from spreading. The skin may take several weeks to heal after treatment, and some patients may experience redness and irritation at the treatment site.

Cryotherapy

Cryotherapy involves freezing the cancerous cells with liquid nitrogen. This treatment destroys the abnormal cells by freezing them, causing them to die and eventually fall off.

Cryotherapy is typically used for small, superficial basal cell carcinomas. It is a quick, in-office procedure that may be repeated if necessary.

Patients can expect some redness and blistering at the treatment site. The skin usually heals within a few weeks, and the cancerous lesion should disappear after treatment.

Dexamethasone

Dexamethasone is a corticosteroid that reduces inflammation and swelling. While not a direct treatment for basal cell carcinoma, it may be used to manage symptoms or side effects of other treatments, such as radiation therapy.

This medication is typically used in cases where inflammation is causing discomfort or complications in treatment. It can be taken orally or applied topically, depending on the patient’s needs.

Patients can expect relief from inflammation and swelling within a few days of starting treatment. It is usually used for short-term symptom management.

Cisplatin

Cisplatin is a chemotherapy drug that works by damaging the DNA of cancer cells, preventing them from growing and dividing. It is used for more advanced or metastatic basal cell carcinoma.

This medication is typically administered intravenously and is reserved for cases where the cancer has spread or when other treatments have failed. It is often used in combination with other chemotherapy agents.

Patients may experience tumor shrinkage and a slowing of cancer progression. The treatment response can be seen within weeks to months, depending on the individual case.

Procedures

Excision

Excision is a surgical procedure in which the cancerous lesion is cut out along with a margin of healthy tissue. This ensures that all cancerous cells are removed.

This procedure is typically used for basal cell carcinomas that are larger or deeper. It is often done in an outpatient setting under local anesthesia.

Patients can expect a small scar after the procedure, but the cancer is usually completely removed. Healing time varies, but most patients recover within a few weeks.

Mohs Surgery

Mohs surgery is a precise surgical technique in which thin layers of cancer-containing skin are progressively removed and examined until only cancer-free tissue remains. It is considered the gold standard for treating basal cell carcinoma.

This procedure is typically used for larger, recurrent, or high-risk basal cell carcinomas, especially those on the face or other sensitive areas. It is performed under local anesthesia and allows for immediate microscopic examination of the tissue.

Patients can expect a high cure rate with minimal scarring. The procedure may take several hours, but it is highly effective in ensuring all cancerous cells are removed.

Curettage and Electrodessication

Curettage and electrodessication involve scraping away the cancerous cells with a curette (a sharp surgical instrument) and then using an electric needle to destroy any remaining cancer cells.

This procedure is typically used for small, superficial basal cell carcinomas. It is performed in an outpatient setting under local anesthesia.

Patients can expect a small scar after the procedure, and the treated area usually heals within a few weeks. The cure rate is high for small lesions.

Improving Basal Cell Carcinoma and Seeking Medical Help

While medical treatments are essential for basal cell carcinoma, several home remedies can support overall skin health. Applying sunscreen daily and avoiding sun exposure are crucial in preventing further damage. Wearing protective clothing, such as wide-brimmed hats and long sleeves, can also reduce the risk of sunburn and skin damage. Regular skin checks, either at home or with a healthcare provider, can help detect any new or recurring lesions early.

Maintaining a healthy diet, staying hydrated, and managing stress are also important for skin health. Some patients find relief by applying aloe vera or green tea extract to soothe irritated skin. Quitting smoking can improve skin health and reduce the risk of complications from basal cell carcinoma. If you notice any new or changing skin lesions, seek medical help promptly.

Telemedicine offers a convenient way to consult with healthcare providers about your skin concerns. Through virtual visits, you can receive advice on managing basal cell carcinoma, discuss treatment options, and even have follow-up appointments without leaving your home.

Living with Basal Cell Carcinoma: Tips for Better Quality of Life

Living with basal cell carcinoma can be challenging, but there are ways to improve your quality of life. Protect your skin by using sunscreen and wearing protective clothing whenever you’re outdoors. Regularly check your skin for any new or changing lesions, and consult your healthcare provider if you notice anything unusual. Managing stress, eating a healthy diet, and staying hydrated can also support your overall well-being.

Telemedicine allows you to stay on top of your treatment plan without the need for frequent in-person visits. Virtual consultations can help you monitor your condition and ensure that you’re receiving the appropriate care. By staying proactive and working closely with your healthcare provider, you can manage basal cell carcinoma effectively and maintain a good quality of life.

Conclusion

Basal cell carcinoma is the most common type of skin cancer, but it is highly treatable, especially when detected early. With a range of treatment options, including medications, surgical procedures, and home remedies, patients can effectively manage their condition and prevent further complications.

Early diagnosis and treatment are critical for achieving the best outcomes. If you notice any new or unusual skin lesions, don’t hesitate to seek medical advice. Our telemedicine practice offers convenient, accessible care, allowing you to consult with healthcare providers from the comfort of your home. Reach out today to schedule a virtual appointment and take the first step toward managing your skin health.

James Kingsley
James Kingsley

Learn More
Scroll to Top